For a decade, the IPF Summit has been the go-to intimate discussion-based forum uniting stakeholders across the pulmonary fibrosis landscape. The 10th IPF Summit is the only end-to-end, industry-led meeting designed to tackle this head-on, bringing together over 150 experts across discovery, translational science, and clinical development, from leading companies. Offering a uniquely integrated view of challenges and opportunities defining the next decade of IPF drug development, from novel biology and biomarker-driven strategies to next-generation trial design and combination approaches, this is where leaders come to align on what success now looks like.